Jaka jest cena za Gaush Meditech Ltd (2407)

Cena za Gaush Meditech Ltd (2407) wynosi $0.56287541

Jaka jest kapitalizacja rynkowa dla Gaush Meditech Ltd (2407)

Kapitalizacja rynkowa dla Gaush Meditech Ltd (2407) wynosi $83.24M

Gaush Meditech Ltd (2407) Stopa Dywidendy

Gaush Meditech Ltd., alongside its affiliates, is engaged in the global research, development, manufacturing, and sale of specialized medical devices for ophthalmology, serving markets both within the People's Republic of China and internationally. The company's operations are divided into four main divisions: Proprietary Products, Distribution, Technical Services, and Other Business Ventures. Its advanced ophthalmic instruments are crucial for the diagnosis, treatment, and surgical intervention of a broad spectrum of eye conditions, including vitreoretinal disorders, cataracts, glaucoma, refractive errors, ocular surface diseases, and issues in optometry and pediatric ophthalmology. The Proprietary Products division focuses on creating and producing its own line of surgical apparatus, accompanying software, intraocular lenses, and equipment for diagnosing and treating eye ailments, along with their associated consumables. Conversely, the Distribution division is responsible for selling diagnostic devices, equipment for ocular fundus examination, surgical and treatment instruments, and related consumables. The Technical Services segment provides essential support, covering warranty services, maintenance, and the supply of post-sales consumables. Lastly, the Other Business Ventures division handles equipment rental, agent registration services, and the licensing of intellectual property. Gaush Meditech Ltd. reaches its clientele—comprising public and private hospitals, among other customers—through both direct sales and a network of distributors. The company was established in 1998 and has its corporate headquarters situated in Beijing, China.

Rok	Stopa dywidendy	Zmień
Za mało danych dla podanych dat.

Rok

Stopa dywidendy

Zmień

Za mało danych dla podanych dat.

Firma	Stopa dywidendy	Kraj
Abbott Laboratories ABT.US	2.23%	US
Stryker Corporation SYK.US	1.03%	US
Medtronic plc MDT.US	3.69%	IE
Boston Scientific Corporation BSX.US	0.00%	US
Siemens Healthineers AG SHL.DE	0.00%	DE

Firma

Stopa dywidendy

Kraj